Navigation Links
Anita Goel to be Featured Luncheon Speaker at FDLI's Annual Nanotechnology Conference
Date:2/13/2009

Top Government Officials Will Explain Regulatory Plans for Cutting-Edge Technology at National Meeting Feb. 18-19 in Washington, DC.

WASHINGTON, Feb. 13 /PRNewswire-USNewswire/ -- Anita Goel, M.D., Ph.D., the founder of Nanobosym, Inc., and Harvard-MIT-trained physicist and physician will deliver the featured luncheon address Feb. 19, 2009 at FDLI's 2nd Annual Conference on Nanotechnology Law, Regulation and Policy Feb. 18-19, in Washington, D.C.

Nanotechnology was incorporated into more than $60 billion in manufactured goods last year. By 2014, the market will grow to $2.6 trillion. By 2011, over $15 billion in nano-enabled drugs and therapeutics will be sold--up from more than $3 billion in 2006. And industry experts project that nanotechnology will be incorporated into $20 billion worth of consumer food products by 2010.

With this rapid commercialization -- and with a new Administration in power - all eyes are on federal government regulators to find out how they intend to deal with this burgeoning issue. FDLI, in partnership with Burdock Group and Arizona State University, has assembled -- in one forum -- top officials at the agencies responsible for the regulation of nanotechnology products -- including the Food and Drug Administration and the Environmental Protection Agency - to discuss their plans for managing and monitoring these products.

FDA speakers include: Norris Alderson, FDA Nanotechnology Task Force; John Weimer, Office of Chief Counsel; Subhas Malghan, Center for Devices and Radiological Health; Linda Katz, Center for Food Safety and Applied Nutrition; Mitchell Cheeseman, Center for Food Safety and Applied Nutrition; and Douglas Throckmorton, Center for Drug Evaluation and Research.

Jessica Barkas, Program Attorney in the Chemical Control Division of the Environmental Protection Agency, also will be speaking at the meeting.

At the meeting at the L'Enfant Plaza Hotel, D.C., food and drug industry representatives also will find out what's happening internationally on nanotech regulation, how venture capitalists look at the future of nanotechnology and what the leading corporations, scientific laboratories and academic centers are focusing on in this dynamic field.

This groundbreaking conference will seek answers to these questions:

  • What progress is FDA making in implementing its Nanotechnology Task Force Report?
  • What can FDA learn from EPA and other oversight agencies in NNI?
  • Will the heavily Democratic Congress invest in and/or regulate more than under the Bush Administration?
  • Are workers exposed to asbestos-like dangers from dealing with nano products?
  • How does a responsible company devise a risk management plan for nanotech development -- one that takes into account OSHA and NIOSH policy?
  • What is reasonable and required federal funding for U.S nanotechnology R&D, including monies for safety and social policy research?
  • Are China and Japan ahead of the U.S. in nanotech development?
  • For nanotech products and processes, should particle size make a regulatory difference?

Other featured speakers and moderators include:

Scott Livingston, Capital Management/The Livingston Group

Andrew Maynard, Woodrow Wilson International Center for Scholars

George Burdock, Burdock Group

Tie Lan, NanoCor Inc.

Robert J. Nicolosi, University of Massachusetts, Lowell

Ralph Hall, University of Minnesota Law School

Matthew Jaffe, Crowell & Moring, LLP

Les Makepeace, Colorado Nanotechnology Alliance

Sean Murdock, NanoBusiness Alliance

Jay Ansell, Personal Care Products Council

James Chen, Crowell & Moring, LLP

John Howard, Public Health Law Program, Centers for Disease Control

Jim O'Reilly, Baker & Daniels

Henry Chajet, Patton Boggs

Rachel Lattimore, Arent Fox

John Monica, Porter Wright

Susan Brienza, Patton Boggs

Lynn L. Bergeson, Bergeson & Campbell, P.C.

Don Ewert, Oso BioPharmaceuticals

Michael J. Kosnett, University of Colorado, Denver and Colorado School of Public Health

Gary Marchant, Arizona State University

Diana Bowman, Monash University

Steffi Friedrichs, Nanotechnology Industries Association

John Pendergrass, Environmental Law Institute

David Guston, Center for Nanotechnology in Society

Jordan Paradise, University of Minnesota Law School

Vickie Sutton, Texas Tech University School of Law

Burdock Group has more than 20 years of expertise regarding ingredient safety and regulatory consultation services. Burdock Group's team offers mission-critical services that include Generally Recognized as Safe (GRAS), New Dietary Ingredient Notifications (NDINs), Consumption Analysis, Claims substantiation, Toxicology and Risk Assessment, Literature Searches and Label Reviews. For more information, visit www.BurdockGroup.com.

The Center for the Study of Law, Science & Technology at Arizona State University is the nation's oldest and largest academic center focusing on the intersection of law with science and technology, and is currently engaged in a three-year study funded by the DOE on regulation of nanotechnology.

To register for the conference, visit www.fdli.org or call (800) 956-6293 or (202) 371-1420.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field. For more information, visit www.fdli.org


'/>"/>
SOURCE Food and Drug Law Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International Medical Corps and Agility Logistics Partner to Enhance Delivery of Humanitarian Relief
2. Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza
3. The American Red Cross Sends Aid as Humanitarian Situation Worsens in Gaza
4. LIFE Provides Emergency Humanitarian Aid to Gaza Civilians and Hospitals
5. Anita Moran AIA Joins WHR Dallas
6. Bloomberg School awards Goodermote Humanitarian Award to Soledad OBrien
7. First U.S. Flight with Humanitarian Goods Arrives in Democratic Republic of Congo
8. Ceasefire Broken in Democratic Republic of Congo; International Medical Corps Warns of Looming Humanitarian Catastrophe and Wider Regional Impact
9. Michael J. Fox Foundation Names Core Programs in Honor of Humanitarian Edmond J. Safra
10. USAID Sends Humanitarian Assistance to the People of Georgia
11. Humanitarian Needs From Georgia Conflict Still Growing, World Vision Warns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology: